Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now full pipeline small index

Memory Disorders: full-pipeline trial registry

6 of 11 indexed Memory Disorders trials are currently recruiting.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 6 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Memory Disorders: 11 US clinical trials tracked, 6 recruiting.

Memory Disorders is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Dartmouth-Hitchcock Medical Center, running 3 of these trials.

Enrollment posture brief

Registry condition memory-disorders

OPEN 6 | RECR 55% | LATE 1 | EARLY 1 | RANK #1577 | SPON 3

Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)

Acute Pancreatitis81.8%Memory Disorders (this)55%Acute Stroke45.5%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Memory Disorders

Memory Disorders lists 6 open slots (55% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Memory Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Memory Disorders is recruiting above its size-band peers.

    6 of 11 indexed trials (54.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Memory Disorders research.

    Dartmouth-Hitchcock Medical Center accounts for 3 of 11 trials (27.3%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Memory Disorders enrolment sits around 125 participants.

    Median target enrolment is 125 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.

  4. Memory Disorders research is mostly interventional.

    8 interventional and 3 observational studies make up this index (72.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31

Open and recent trials

11 total, page 1 of 1

RECRUITING 1,200 participants

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

GAP Innovations, PBC

NCT06584357

RECRUITING NA 150 participants

Brain Health Virtual Reality Study

University of California, San Diego

NCT06124339

RECRUITING NA 125 participants

HOBSCOTCH-MS-Efficacy Trial

Dartmouth-Hitchcock Medical Center

NCT06951919

RECRUITING 100 participants

Neural Correlates of Psychiatric Disorders

Vanderbilt University Medical Center

NCT04725409

RECRUITING NA 90 participants

Amygdala Memory Enhancement

Washington University School of Medicine

NCT05065450

RECRUITING Early Phase 1 60 participants

Pharmacological Modulation of Brain Oscillations in Memory Processing

University of Texas Southwestern Medical Center

NCT05594017

ACTIVE NOT RECRUITING NA 263 participants

Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention

University of California, Davis

NCT05027789

ACTIVE NOT RECRUITING NA 11 participants

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)

Dartmouth-Hitchcock Medical Center

NCT06145737

ACTIVE NOT RECRUITING NA 10 participants

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)

Dartmouth-Hitchcock Medical Center

NCT06260228

COMPLETED 360 participants

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

University of Pennsylvania

NCT02225041

COMPLETED Phase 3

Preventing Cognitive Decline With Alternative Therapies

National Center for Complementary and Integrative Health (NCCIH)

NCT00010920

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Named interventions

Most-linked intervention names on Memory Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH) Behavioral
2 trials
Ginkgo Biloba Extract Drug
1 trials
Structured Group Behavioral
1 trials
Home Based Self- management and Cognitive Training Changes lives in Multiple Sclerosis (HOBSCOTCH-MS) Behavioral
1 trials
Scopolamine (0.4mg) Drug
1 trials
Physical and Cognitive Activity Behavioral
1 trials
Cognitive Activity (VR) Behavioral
1 trials
Self-Guided Behavioral
1 trials

US sites by state

Facility locations filed on Memory Disorders trials. A trial with sites in several states counts in each.

New Hampshire 3 trials
California 3 trials
Missouri 2 trials
Michigan 2 trials
Illinois 2 trials
Florida 2 trials
Texas 1 trials
Tennessee 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Memory Disorders page

11 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Memory Disorders condition card totals 11 registered trials; most-linked intervention HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH); top US site state New Hampshire. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.